Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease

NCT02103465 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

80

Enrollment

OTHER

Sponsor class

Stopped Because the rate of recruitment was very slow

Conditions

Parkinson's Disease

Interventions

DRUG: Rotigotine
DRUG: Placebo

Sponsor

Azienda Ospedaliera Cardinale G. Panico